What Happened?
San Diego, CA-based Cypher Genomics has Appointed Patrick J. Ravenel as Chief Technology Officer
About the Company
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.
About the Person
Patrick Ravenel is a major contributor to the design, development and deployment of high-performance distributed computing solutions. His career has focused on high performance financial trading, commercial electronic data interchange (EDI), security, compliance and analytic systems. He was previously vice president of software development at MedImpact Healthcare Systems. Prior to MedImpact, he had successful exits (both acquisition and IPO) as a co-founder and a director in the areas of security and distributed transactional caching environments. In addition to his published papers, articles and book contributions, Mr. Ravenel has four patents in information security and automated compliance management. He holds a B.A. in Applied Mathematics and Scientific Programming from the University of California, San Diego.
Info Source
News
Short Profile